WMP
OTLK icon

Wealth Management Partners’s Outlook Therapeutics OTLK Stock Holding History

Wealth Management Partners’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$188K Buy
+118,170
New +$73.3K 0.04% 153

Other funds holding OTLK

GWM
Gilpin Wealth Management Denver, Colorado $145M AUM
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
CKAIS
Christensen King & Associates Investment Services Richland, Washington $252M AUM 20.51% 1-Year Est. Return
FCC
Flower City Capital Pittsford, New York $227M AUM 23.31% 1-Year Est. Return
OFS
Orrstown Financial Services Harrisburg, Pennsylvania $674M AUM 23.23% 1-Year Est. Return
FTWA
Fifth Third Wealth Advisors Cincinnati, Ohio $3.58B AUM 34.55% 1-Year Est. Return
GA
GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Wealth Management Partners's OTLK Position: Q2 2026 in Review

Wealth Management Partners opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 118,170 shares worth $188K. The stake represents 0.04% of the portfolio and ranks #153 among its holdings.

13 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Wealth Management Partners held 118,170 shares of Outlook Therapeutics worth $188K as of Q2 2026.
  • Outlook Therapeutics was a new Wealth Management Partners position in Q2 2026.
  • Outlook Therapeutics made up 0.04% of Wealth Management Partners's portfolio in Q2 2026, its #153 holding.
  • 13 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Wealth Management Partners's 13F filing for Q2 2026, filed 22 Jul 2026.